FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2883920716> ?p ?o ?g. }

• W2883920716 endingPage "201e" @default.
• W2883920716 startingPage "192e" @default.
• W2883920716 abstract "Background: Connective tissue growth factor (CTGF) levels are up-regulated in wounded skin and are thought to play a major role in scar formation. An antisense oligonucleotide targeting CTGF was evaluated in adult patients undergoing hypertrophic scar revision surgery, to determine effects on reducing the severity of subsequent scars. Methods: In a randomized, double-blind, within-subject, placebo-controlled study, 23 female subjects (aged 28 to 55 years) with bilateral, symmetric, hypertrophic surgical scars of the breast underwent scar revision surgery. The resulting breast incisions were randomized to receive EXC 001 (5 mg/cm) or placebo injected intradermally at postsurgery weeks 2, 5, 8, and 11. Scar severity assessments were performed at weeks 12 and 24 by an expert panel using blinded photographs, and by physicians and subjects using a scar scoring scale, the Patient and Observer Scar Assessment Scale. An assumption of the design is that within-subject variance would be small and that whatever within-subject variance there was would be controlled through the randomization process. Results: EXC 001 significantly reduced scar severity at both 12 and 24 weeks after scar revision surgery in all three measures (expert panel and physician Patient and Observer Scar Assessment Scale, p < 0.001; Patient and Observer Scar Assessment Scale, p < 0.003). Conclusions: This study provided positive preliminary data that intradermal injection of EXC 001 produced a significant reduction in severity of postsurgical skin scars, as measured by physicians, subjects, and an expert panel. This study provided evidence that suppression of CTGF could be a viable strategy for hypertrophic scar reduction therapy and that further study of the antisense oligonucleotide EXC 001 was indicated. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II." @default.
• W2883920716 created "2018-08-03" @default.
• W2883920716 creator A5058324393 @default.
• W2883920716 creator A5063228443 @default.
• W2883920716 creator A5072985008 @default.
• W2883920716 creator A5076567607 @default.
• W2883920716 creator A5077252569 @default.
• W2883920716 creator A5078740006 @default.
• W2883920716 creator A5082048272 @default.
• W2883920716 creator A5084824434 @default.
• W2883920716 creator A5088823823 @default.
• W2883920716 date "2018-08-01" @default.
• W2883920716 modified "2023-10-14" @default.
• W2883920716 title "Anti-CTGF Oligonucleotide Reduces Severity of Postsurgical Hypertrophic Scars in a Randomized, Double-Blind, Within-Subject, Placebo-Controlled Study" @default.
• W2883920716 cites W1606096607 @default.
• W2883920716 cites W1798749130 @default.
• W2883920716 cites W1989410388 @default.
• W2883920716 cites W2047151166 @default.
• W2883920716 cites W2060119002 @default.
• W2883920716 cites W2093889935 @default.
• W2883920716 cites W2112500666 @default.
• W2883920716 cites W2116323280 @default.
• W2883920716 cites W2127630375 @default.
• W2883920716 cites W2156135044 @default.
• W2883920716 cites W2184184250 @default.
• W2883920716 doi "https://doi.org/10.1097/prs.0000000000004590" @default.
• W2883920716 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30045185" @default.
• W2883920716 hasPublicationYear "2018" @default.
• W2883920716 type Work @default.
• W2883920716 sameAs 2883920716 @default.
• W2883920716 citedByCount "13" @default.
• W2883920716 countsByYear W28839207162018 @default.
• W2883920716 countsByYear W28839207162020 @default.
• W2883920716 countsByYear W28839207162021 @default.
• W2883920716 countsByYear W28839207162022 @default.
• W2883920716 countsByYear W28839207162023 @default.
• W2883920716 crossrefType "journal-article" @default.
• W2883920716 hasAuthorship W2883920716A5058324393 @default.
• W2883920716 hasAuthorship W2883920716A5063228443 @default.
• W2883920716 hasAuthorship W2883920716A5072985008 @default.
• W2883920716 hasAuthorship W2883920716A5076567607 @default.
• W2883920716 hasAuthorship W2883920716A5077252569 @default.
• W2883920716 hasAuthorship W2883920716A5078740006 @default.
• W2883920716 hasAuthorship W2883920716A5082048272 @default.
• W2883920716 hasAuthorship W2883920716A5084824434 @default.
• W2883920716 hasAuthorship W2883920716A5088823823 @default.
• W2883920716 hasConcept C141071460 @default.
• W2883920716 hasConcept C14184104 @default.
• W2883920716 hasConcept C142724271 @default.
• W2883920716 hasConcept C168563851 @default.
• W2883920716 hasConcept C204243189 @default.
• W2883920716 hasConcept C204787440 @default.
• W2883920716 hasConcept C27081682 @default.
• W2883920716 hasConcept C2777642821 @default.
• W2883920716 hasConcept C2778698245 @default.
• W2883920716 hasConcept C3019227704 @default.
• W2883920716 hasConcept C71924100 @default.
• W2883920716 hasConceptScore W2883920716C141071460 @default.
• W2883920716 hasConceptScore W2883920716C14184104 @default.
• W2883920716 hasConceptScore W2883920716C142724271 @default.
• W2883920716 hasConceptScore W2883920716C168563851 @default.
• W2883920716 hasConceptScore W2883920716C204243189 @default.
• W2883920716 hasConceptScore W2883920716C204787440 @default.
• W2883920716 hasConceptScore W2883920716C27081682 @default.
• W2883920716 hasConceptScore W2883920716C2777642821 @default.
• W2883920716 hasConceptScore W2883920716C2778698245 @default.
• W2883920716 hasConceptScore W2883920716C3019227704 @default.
• W2883920716 hasConceptScore W2883920716C71924100 @default.
• W2883920716 hasIssue "2" @default.
• W2883920716 hasLocation W28839207161 @default.
• W2883920716 hasOpenAccess W2883920716 @default.
• W2883920716 hasPrimaryLocation W28839207161 @default.
• W2883920716 hasRelatedWork W2086411372 @default.
• W2883920716 hasRelatedWork W2088312076 @default.
• W2883920716 hasRelatedWork W2173877571 @default.
• W2883920716 hasRelatedWork W2322465317 @default.
• W2883920716 hasRelatedWork W2353503117 @default.
• W2883920716 hasRelatedWork W2353972822 @default.
• W2883920716 hasRelatedWork W2997600033 @default.
• W2883920716 hasRelatedWork W3029136108 @default.
• W2883920716 hasRelatedWork W3031727326 @default.
• W2883920716 hasRelatedWork W4294732857 @default.
• W2883920716 hasVolume "142" @default.
• W2883920716 isParatext "false" @default.
• W2883920716 isRetracted "false" @default.
• W2883920716 magId "2883920716" @default.
• W2883920716 workType "article" @default.